Serum Hepcidin: a Novel Diagnostic Tool in Disorders of Iron Metabolism

Overview

Journal Haematologica

Specialty Hematology

Date 2009 Dec 10

PMID 19996112

Citations 9

Authors

Gaetano Bergamaschi

Laura Villani

Affiliations

Soon will be listed here.

Citing Articles

Apo- and holo-transferrin differentially interact with hephaestin and ferroportin in a novel mechanism of cellular iron release regulation.

Baringer S, Palsa K, Spiegelman V, Simpson I, Connor J J Biomed Sci. 2023; 30(1):36.

PMID: 37277838 PMC: 10243088. DOI: 10.1186/s12929-023-00934-2.

Apo- and holo- transferrin differentially interact with ferroportin and hephaestin to regulate iron release at the blood-brain barrier.

Baringer S, Palsa K, Simpson I, Connor J bioRxiv. 2023; .

PMID: 36712094 PMC: 9882075. DOI: 10.1101/2023.01.10.522344.

Apo- and holo- transferrin differentially interact with ferroportin and hephaestin to regulate iron release at the blood-brain barrier.

Baringer S, Palsa K, Simpson I, Connor J Res Sq. 2023; .

PMID: 36711476 PMC: 9882672. DOI: 10.21203/rs.3.rs-2429356/v1.

Effects of Feeding 5-Aminolevulinic Acid on Iron Status in Weaned Rats from the Female Rats during Gestation and Lactation.

Li J, Xie Y, Li M, Zhang S, Cheng Q, Yang W Animals (Basel). 2022; 12(20).

PMID: 36290255 PMC: 9598332. DOI: 10.3390/ani12202869.

Anemia of Chronic Diseases: Wider Diagnostics-Better Treatment?.

Wicinski M, Liczner G, Cadelski K, Kolnierzak T, Nowaczewska M, Malinowski B Nutrients. 2020; 12(6).

PMID: 32560029 PMC: 7353365. DOI: 10.3390/nu12061784.

References

De Domenico I, Ward D, Kaplan J . Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol. 2007; 9(1):72-81. DOI: 10.1038/nrm2295. View

Park C, Valore E, Waring A, Ganz T . Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2000; 276(11):7806-10. DOI: 10.1074/jbc.M008922200. View

van Dijk B, Laarakkers C, Klaver S, Jacobs E, van Tits L, Janssen M . Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol. 2008; 142(6):979-85. DOI: 10.1111/j.1365-2141.2008.07273.x. View

Pak M, Lopez M, Gabayan V, Ganz T, Rivera S . Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006; 108(12):3730-5. PMC: 1895477. DOI: 10.1182/blood-2006-06-028787. View

Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C . Hepcidin is decreased in TFR2 hemochromatosis. Blood. 2004; 105(4):1803-6. DOI: 10.1182/blood-2004-08-3042. View

Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E . Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood. 2007; 110(12):4096-100. DOI: 10.1182/blood-2007-06-096503. View

Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A . Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 2001; 98(15):8780-5. PMC: 37512. DOI: 10.1073/pnas.151179498. View

Kemna E, Tjalsma H, Willems H, Swinkels D . Hepcidin: from discovery to differential diagnosis. Haematologica. 2008; 93(1):90-7. DOI: 10.3324/haematol.11705. View

Zhang A, Enns C . Iron homeostasis: recently identified proteins provide insight into novel control mechanisms. J Biol Chem. 2008; 284(2):711-5. PMC: 2613612. DOI: 10.1074/jbc.R800017200. View

10.

Ganz T, Nemeth E . Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006; 290(2):G199-203. DOI: 10.1152/ajpgi.00412.2005. View

11.

Papanikolaou G, Tzilianos M, Christakis J, Bogdanos D, Tsimirika K, MacFarlane J . Hepcidin in iron overload disorders. Blood. 2005; 105(10):4103-5. PMC: 1895089. DOI: 10.1182/blood-2004-12-4844. View

12.

Zoller H, McFarlane I, Theurl I, Stadlmann S, Nemeth E, Oxley D . Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology. 2005; 42(2):466-72. DOI: 10.1002/hep.20775. View

13.

Nemeth E, Tuttle M, Powelson J, Vaughn M, Donovan A, Ward D . Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306(5704):2090-3. DOI: 10.1126/science.1104742. View

14.

Huang H, Constante M, Layoun A, Santos M . Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood. 2009; 113(15):3593-9. PMC: 2891008. DOI: 10.1182/blood-2008-08-173641. View

15.

Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P . A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2000; 276(11):7811-9. DOI: 10.1074/jbc.M008923200. View

16.

Nemeth E, Preza G, Jung C, Kaplan J, Waring A, Ganz T . The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood. 2005; 107(1):328-33. PMC: 1895343. DOI: 10.1182/blood-2005-05-2049. View

17.

Camaschella C, Poggiali E . Towards explaining "unexplained hyperferritinemia". Haematologica. 2009; 94(3):307-9. PMC: 2649347. DOI: 10.3324/haematol.2008.005405. View

18.

Cazzola M, Della Porta M, Malcovati L . Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2008; :166-75. DOI: 10.1182/asheducation-2008.1.166. View

19.

Krause A, Neitz S, Magert H, Schulz A, Forssmann W, Schulz-Knappe P . LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000; 480(2-3):147-50. DOI: 10.1016/s0014-5793(00)01920-7. View

20.

Piperno A, Mariani R, Trombini P, Girelli D . Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol. 2009; 15(5):538-51. PMC: 2653344. DOI: 10.3748/wjg.15.538. View